NCT06174051

Brief Summary

The goal of this randomized controlled trial is to test whether flashforward (FF) EMDR alone is effective in reducing anxiety symptoms in patients with an implantable cardioverter defibrillator (ICD). Participants will fill out several questionnaires to asses their level of anxiety, depression symptoms and quality of life before, during and after treatment.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
33

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2024

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 8, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 18, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

February 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
Last Updated

December 19, 2023

Status Verified

December 1, 2023

Enrollment Period

1 year

First QC Date

December 8, 2023

Last Update Submit

December 18, 2023

Conditions

Keywords

EMDRFlashforwardAnxietyICD

Outcome Measures

Primary Outcomes (1)

  • Cardiac Anxiety Questionnaire (CAQ)

    Self-report questionnaire to asses heart focussed anxiety

    Baseline (Before treatment T0), after the first treatment session T1(for wait list after 2 weeks), and after the second treatment session T2 (for wait list after 4 weeks)

Secondary Outcomes (4)

  • PTSD Check-List (PCL-5)

    Baseline (Before treatment T0) and after the second treatment session T2 (for wait list after 4 weeks)

  • General Anxiety Questionnaire (GAD-7)

    Baseline (Before treatment T0) and after the second treatment session T2 (for wait list after 4 weeks)

  • Patient Health Questionnaire (PHQ-9)

    Baseline (Before treatment T0) and after the second treatment session T2 (for wait list after 4 weeks)

  • EuroQol (EQ5D-5L)

    Baseline (Before treatment T0) and after the second treatment session T2 (for wait list after 4 weeks)

Other Outcomes (1)

  • Life Events Checklist (LEC-5)

    Baseline (Before treatment T0)

Study Arms (3)

FF EMDR

EXPERIMENTAL

Subjects in this group will receive two EMDR treatment sessions following the flashforward protocol.

Behavioral: Flashforward EMDR

FB EMDR

ACTIVE COMPARATOR

Subjects in this group will receive two EMDR treatment sessions following the flashback protocol.

Behavioral: Flashback EMDR

Control group

NO INTERVENTION

Subjects in this group will not receive any treatment until the wait list period (4 weeks) is over

Interventions

The Flashforward procedure in EMDR-treatment aims to reduce fear evoked by images of imagined future adverse events.

FF EMDR
Flashback EMDRBEHAVIORAL

The Flashback procedure in EMDR-treatment aims to successfuly process the memories of traumatic events that happened in the past.

FB EMDR

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • subjects have an ICD;
  • subjects have clinical anxiety symptoms related to their ICD.

You may not qualify if:

  • insufficient knowledge on Dutch or English language;
  • severe psychiatric disorders that warrant (other) psychiatric first, such as suicidality or psychotic disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Central Study Contacts

Leonieke Kranenburg, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
The study will have an open label, since the care provider (the psychologist) needs to know which procedure to follow and the participants will understand in which group they are once the therapy start.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: In this study, three groups are compared in a parallel setting. One group will receive EMDR following the flashforward procedure, one group will receive EMDR following the flashback procedure, and the last group will be on a wait list and fill out the questionnaires without receiving EMDR treatment.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

December 8, 2023

First Posted

December 18, 2023

Study Start

February 1, 2024

Primary Completion

February 1, 2025

Study Completion

July 1, 2025

Last Updated

December 19, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Data will be available, anonymized, to other researchers, upon reasonable request.